Resources

Medical professional

Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management.  Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.

 

Showing 21 to 30 of 236 resources

  • Needle Exchange Surveillance Initiative: 2008-9 to 2015-16
    The Needle Exchange Surveillance Initiative measures and monitorings the prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs in Scotland. This report presents the results, at the NHS board level, for the data collection period from February 2015 until March 2016. It also presents the findings of the NESI survey, at Scotland-wide level, from 2008-09 until the most recent survey, 2015-16.
    UK, Scotland Mar 2017 Reports & Research PDF
  • Evaluation of the South West Hepatitis C Partnership Pilot
    An evaluation of a project in which Addaction and The Hepatitis C Trust partnered together to support people with a history of injecting drug use who were engaged with Addaction services into hepatitis C treatment. This report evaluates the success of the pilot's three key interventions:

    * Peer education workshops

    * A 'buddy' scheme

    * Workforce development

    South West Reports & Research PDF
  • Good practice case study: Nottingham outreach clinics
    This HCV Action good practice case study looks at the community outreach work done by Nottingham University Hospitals NHS Trust. Statistics showed that between 2000 and 2002, 256 people were diagnosed with hepatitis C in Nottingham. Of these, just 49% were referred to a specialist clinic, 27% attended and 10% received treatment. During the 2010-12 period, after the establishment of community outreach services in the area, 80% of people diagnosed were referred to a specialist clinic, 70% attended and 38% started treatment.
    UK, East Midlands Case study PDF
  • Hepatitis C in England 2017 report
    This report by Public Health England has been produced to support monitoring of the recently agreed Global Health Sector Strategy on Viral Hepatitis goals, including the elimination of hepatitis C as a major public health threat by 2030. The report summarises the impact of action plans in England to drive down mortality from hepatitis C, reduce the number of new infections, and outlines the actions required to make further progress.
    England Mar 2017 Reports & Research, Strategy & Planning PDF
  • Hepatitis C in England 2017: Headline table
    This table, produced by Public Health England to accompany 'Hepatitis C in England: 2017 report', collates the key statistics and information related to hepatitis C in England, including burden of infection; mortality and morbidity; incidence of infections; adequacy of harm reduction services; diagnosis rates, and the numbers of people accessing treatment.
    England Mar 2017 Reports & Research PDF
  • Summary report: Midlands & East Hepatitis C Educational Event, Nottingham
    This report provides a summary of the Midlands & East Hepatitis C Educational Event held by HCV Action and NHS England in Nottingham on Friday 10th February 2017.
    UK, East Midlands Reports & Research PDF
  • Midlands & East Hepatitis C Educational Event in Nottingham: Presentations
    On Friday 10th February 2017, HCV Action and NHS England held a Midlands & East Hepatitis C Educational Event in Nottingham. With hepatitis C Operational Delivery Networks (ODNs) still relatively new in operation, the event was held with the aim of offering the chance for ODNs across the Midlands and East region to come together to discuss their experiences, share best practice and develop solutions to some of the challenges they face as they seek to ensure the highest standards of hepatitis C care and treatment.
    UK, East Midlands Reports & Research MS Powerpoint
  • Guidelines on hepatitis B and C testing
    These are the first WHO guidelines on testing for chronic hepatitis B and C infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for hepatitis B and C, and are intended for use across age groups and populations.
    Rest of World Feb 2017 Other, Strategy & Planning PDF
  • Access and Uptake of Direct Acting Antiviral Medicines in the UK and selected European countries
    This report, produced by IMS Health and commissioned by the Association of the British Pharmaceutical Industry (ABPI), provides information related to the uptake of Direct Acting Antiviral treatments (DAAs) over the last five years, to June 2016. The intention of the report is to benchmark the UK – in relation to patient access to these medicines – compared with other European countries. It finds that there have been significant variances in the ability of patients to access these medicines.
    UK Feb 2017 Reports & Research PDF
  • ChemSex and hepatitis C: a guide for healthcare providers
    A guide for healthcare providers on those at risk of contracting hepatitis C through ChemSex, featuring key facts, transmission risks, suggestions for engaging with those at risk, terms to be familiar with and a case study.
    UK Reports & Research, Tools & Templates PDF

Pages